Physician profile
Jonathan D King
NPI 1811938830
$3,637.18
in general payments reported to CMS, 2019-2025
17 companies · $239 in 2025
The $239 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.36 · 2020: $41.18 · 2021: $637 · 2022: $1,984 · 2023: $437 · 2024: $256 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $834 · Education: $98.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $833.52 |
| Education | $98.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,236.28 | 2021-2025 | Inspire |
| Optinose US, INC. | $555.21 | 2019-2025 | |
| Genzyme Corporation | $268.06 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $119.82 | 2021-2023 | Dupixent |
| Aerin Medical INC. | $91.38 | 2020-2024 | |
| Glaxosmithkline, LLC. | $48.71 | 2022-2025 | Nucala |
| Kerecis Limited | $46.67 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Alk-Abello, INC | $41.43 | 2019-2021 | |
| Amgen INC. | $38.78 | 2025 | Tezspire |
| Integra Lifesciences Corporation | $35.27 | 2024-2025 | Acclarent Aera, Inspira Air, Trudi Probe |
| Hikma Pharmaceuticals USA | $34.89 | 2023 | Ryaltris |
| Medtronic, INC. | $31.68 | 2023-2024 | Pteye Parathyroid Detection System, Stealthstation S8 Platform |
| Novartis Pharmaceuticals Corporation | $28.21 | 2024 | |
| Acclarent, INC | $27.25 | 2023 | Acclarent Aera, Trudi Nav Cable |
| Smith+Nephew, INC. | $19.98 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $13.56 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.